Humana Inc. (NYSE:HUM) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday, June 21st.
Other equities analysts have also issued reports about the company. Cowen and Company reiterated an “outperform” rating and set a $230.00 price objective on shares of Humana in a research report on Tuesday, April 25th. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $257.00 target price for the company in a report on Thursday, May 25th. Leerink Swann increased their target price on Humana from $250.00 to $265.00 and gave the company an “outperform” rating in a report on Tuesday, May 30th. Jefferies Group LLC restated a “hold” rating and set a $230.00 target price (up from $221.00) on shares of Humana in a report on Thursday, May 4th. Finally, Evercore ISI reiterated an “outperform” rating and issued a $240.00 price objective on shares of Humana in a report on Tuesday, April 25th. Ten investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $232.86.
Shares of Humana (NYSE:HUM) traded up 0.04% during midday trading on Wednesday, hitting $235.92. 1,013,821 shares of the stock traded hands. Humana has a 1-year low of $163.50 and a 1-year high of $243.74. The company has a market capitalization of $34.05 billion, a P/E ratio of 24.04 and a beta of 0.91. The stock has a 50 day moving average of $235.90 and a 200 day moving average of $218.69.
Humana (NYSE:HUM) last announced its earnings results on Wednesday, May 3rd. The insurance provider reported $2.75 earnings per share for the quarter, topping analysts’ consensus estimates of $2.55 by $0.20. The business had revenue of $13.76 billion for the quarter, compared to analyst estimates of $13.61 billion. Humana had a return on equity of 14.38% and a net margin of 2.71%. During the same period in the prior year, the company earned $1.86 EPS. Equities research analysts predict that Humana will post $11.15 earnings per share for the current fiscal year.
WARNING: “Humana Inc. (NYSE:HUM) Lifted to “Buy” at BidaskClub” was published by BNB Daily and is the sole property of of BNB Daily. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.baseball-news-blog.com/2017/07/22/bidaskclub-upgrades-humana-inc-hum-to-buy-updated-updated.html.
In other news, VP Timothy S. Huval sold 13,939 shares of Humana stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $225.86, for a total value of $3,148,262.54. Following the sale, the vice president now directly owns 23,639 shares of the company’s stock, valued at $5,339,104.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Bruce D. Broussard sold 118,231 shares of Humana stock in a transaction dated Thursday, May 4th. The stock was sold at an average price of $225.82, for a total value of $26,698,924.42. Following the completion of the sale, the chief executive officer now directly owns 171,170 shares in the company, valued at $38,653,609.40. The disclosure for this sale can be found here. Insiders sold 143,241 shares of company stock worth $32,446,903 over the last 90 days. Company insiders own 0.80% of the company’s stock.
Several large investors have recently modified their holdings of the company. Guardian Life Insurance Co. of America boosted its stake in shares of Humana by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock valued at $119,000 after buying an additional 4 shares during the period. Independent Portfolio Consultants Inc. boosted its stake in shares of Humana by 22.1% in the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock valued at $125,000 after buying an additional 94 shares during the period. Point72 Asia Hong Kong Ltd bought a new stake in shares of Humana during the first quarter valued at $128,000. Westbourne Investment Advisors Inc. bought a new stake in shares of Humana during the second quarter valued at $205,000. Finally, Hengehold Capital Management LLC bought a new stake in shares of Humana during the second quarter valued at $209,000. 99.04% of the stock is currently owned by hedge funds and other institutional investors.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.